PIMREG and breast cancer: Several studies have shown that overexpression of FAM64A accelerated the proliferation, migration, and invasion of esophageal cancer cells, breast cancer, pancreatic cancer, lymphoma, and other tumor tissues than normal tissues [7–9, 12].